Surmodics, Inc. (SRDX)
USD 29.25
(-2.86%)
USD 29.25
(-2.86%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 126.07 Million USD | -4.91% |
| 2023 | 132.58 Million USD | 32.65% |
| 2022 | 99.95 Million USD | -4.93% |
| 2021 | 105.13 Million USD | 10.83% |
| 2020 | 94.86 Million USD | -5.21% |
| 2019 | 100.07 Million USD | 23.04% |
| 2018 | 81.33 Million USD | 11.25% |
| 2017 | 73.11 Million USD | 2.45% |
| 2016 | 71.36 Million USD | 15.3% |
| 2015 | 61.89 Million USD | 7.76% |
| 2014 | 57.43 Million USD | 2.33% |
| 2013 | 56.13 Million USD | 8.1% |
| 2012 | 51.92 Million USD | -23.39% |
| 2011 | 67.78 Million USD | -3.03% |
| 2010 | 69.89 Million USD | -42.49% |
| 2009 | 121.53 Million USD | 25.23% |
| 2008 | 97.05 Million USD | 32.65% |
| 2007 | 73.16 Million USD | 4.69% |
| 2006 | 69.88 Million USD | 12.03% |
| 2005 | 62.38 Million USD | 25.42% |
| 2004 | 49.73 Million USD | 15.05% |
| 2003 | 43.23 Million USD | 46.61% |
| 2002 | 29.48 Million USD | 29.94% |
| 2001 | 22.69 Million USD | 24.15% |
| 2000 | 18.27 Million USD | 35.4% |
| 1999 | 13.5 Million USD | 37.76% |
| 1998 | 9.8 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 31.95 Million USD | 4.6% |
| 2024 Q3 | 30.34 Million USD | -5.06% |
| 2024 Q1 | 30.55 Million USD | 9.23% |
| 2023 Q1 | 24.93 Million USD | -4.06% |
| 2023 FY | 132.58 Million USD | 32.65% |
| 2023 Q3 | 52.48 Million USD | 92.97% |
| 2023 Q2 | 27.19 Million USD | 9.08% |
| 2023 Q4 | 27.97 Million USD | -46.71% |
| 2022 Q1 | 23 Million USD | -4.04% |
| 2022 Q2 | 26.1 Million USD | 13.49% |
| 2022 FY | 99.95 Million USD | -4.93% |
| 2022 Q3 | 24.85 Million USD | -4.8% |
| 2022 Q4 | 25.98 Million USD | 4.56% |
| 2021 FY | 105.13 Million USD | 10.83% |
| 2021 Q3 | 23.87 Million USD | -31.78% |
| 2021 Q2 | 34.99 Million USD | 56.95% |
| 2021 Q1 | 22.29 Million USD | -1.09% |
| 2021 Q4 | 23.97 Million USD | 0.41% |
| 2020 Q4 | 22.54 Million USD | -16.14% |
| 2020 Q1 | 22.61 Million USD | -26.61% |
| 2020 Q2 | 22.82 Million USD | 0.91% |
| 2020 FY | 94.86 Million USD | -5.21% |
| 2020 Q3 | 26.88 Million USD | 17.79% |
| 2019 Q3 | 24.34 Million USD | 7.36% |
| 2019 Q1 | 22.24 Million USD | -3.46% |
| 2019 Q2 | 22.67 Million USD | 1.96% |
| 2019 FY | 100.07 Million USD | 23.04% |
| 2019 Q4 | 30.81 Million USD | 26.59% |
| 2018 Q4 | 23.03 Million USD | 3.65% |
| 2018 FY | 81.33 Million USD | 11.25% |
| 2018 Q2 | 19.05 Million USD | 12.02% |
| 2018 Q1 | 17.01 Million USD | -15.18% |
| 2018 Q3 | 22.22 Million USD | 16.63% |
| 2017 FY | 73.11 Million USD | 2.45% |
| 2017 Q4 | 20.05 Million USD | 12.75% |
| 2017 Q3 | 17.79 Million USD | 1.64% |
| 2017 Q2 | 17.5 Million USD | -1.45% |
| 2017 Q1 | 17.76 Million USD | -2.16% |
| 2016 Q1 | 16.54 Million USD | -4.74% |
| 2016 Q3 | 19.97 Million USD | 19.6% |
| 2016 Q2 | 16.69 Million USD | 0.96% |
| 2016 Q4 | 18.15 Million USD | -9.1% |
| 2016 FY | 71.36 Million USD | 15.3% |
| 2015 Q3 | 15.91 Million USD | 10.4% |
| 2015 Q4 | 17.36 Million USD | 9.11% |
| 2015 Q1 | 14.2 Million USD | -7.37% |
| 2015 FY | 61.89 Million USD | 7.76% |
| 2015 Q2 | 14.41 Million USD | 1.48% |
| 2014 Q3 | 14.61 Million USD | 7.44% |
| 2014 Q1 | 13.88 Million USD | -2.9% |
| 2014 FY | 57.43 Million USD | 2.33% |
| 2014 Q2 | 13.6 Million USD | -2.01% |
| 2014 Q4 | 15.33 Million USD | 4.93% |
| 2013 Q3 | 14.28 Million USD | 4.34% |
| 2013 Q1 | 13.85 Million USD | 0.06% |
| 2013 Q4 | 14.29 Million USD | 0.06% |
| 2013 Q2 | 13.69 Million USD | -1.13% |
| 2013 FY | 56.13 Million USD | 8.1% |
| 2012 Q1 | 11.91 Million USD | -30.53% |
| 2012 FY | 51.92 Million USD | -23.39% |
| 2012 Q4 | 13.84 Million USD | -0.83% |
| 2012 Q3 | 13.95 Million USD | 14.32% |
| 2012 Q2 | 12.21 Million USD | 2.47% |
| 2011 FY | 67.78 Million USD | -3.03% |
| 2011 Q3 | 17.96 Million USD | 2.7% |
| 2011 Q2 | 17.49 Million USD | 15.33% |
| 2011 Q4 | 17.15 Million USD | -4.54% |
| 2011 Q1 | 15.16 Million USD | -2.45% |
| 2010 FY | 69.89 Million USD | -42.49% |
| 2010 Q3 | 18.6 Million USD | 1.35% |
| 2010 Q4 | 15.54 Million USD | -16.44% |
| 2010 Q2 | 18.36 Million USD | 5.63% |
| 2010 Q1 | 17.38 Million USD | -9.51% |
| 2009 Q3 | 18.18 Million USD | -13.09% |
| 2009 Q1 | 63.21 Million USD | 172.03% |
| 2009 Q2 | 20.92 Million USD | -66.9% |
| 2009 FY | 121.53 Million USD | 25.23% |
| 2009 Q4 | 19.2 Million USD | 5.61% |
| 2008 Q1 | 23.82 Million USD | 11.88% |
| 2008 FY | 97.05 Million USD | 32.65% |
| 2008 Q4 | 23.23 Million USD | -4.27% |
| 2008 Q3 | 24.27 Million USD | -5.57% |
| 2008 Q2 | 25.7 Million USD | 7.88% |
| 2007 Q1 | 16.74 Million USD | -4.74% |
| 2007 FY | 73.16 Million USD | 4.69% |
| 2007 Q4 | 21.29 Million USD | 19.91% |
| 2007 Q3 | 17.76 Million USD | 2.3% |
| 2007 Q2 | 17.36 Million USD | 3.72% |
| 2006 FY | 69.88 Million USD | 12.03% |
| 2006 Q1 | 16.46 Million USD | 2.33% |
| 2006 Q2 | 17.7 Million USD | 7.54% |
| 2006 Q3 | 18.13 Million USD | 2.44% |
| 2006 Q4 | 17.57 Million USD | -3.12% |
| 2005 FY | 62.38 Million USD | 25.42% |
| 2005 Q4 | 16.09 Million USD | -2.59% |
| 2005 Q3 | 16.51 Million USD | 5.18% |
| 2005 Q2 | 15.7 Million USD | 11.63% |
| 2005 Q1 | 14.06 Million USD | 4.45% |
| 2004 FY | 49.73 Million USD | 15.05% |
| 2004 Q4 | 13.46 Million USD | 17.69% |
| 2004 Q1 | 12.08 Million USD | -4.25% |
| 2004 Q2 | 12.73 Million USD | 5.39% |
| 2004 Q3 | 11.44 Million USD | -10.16% |
| 2003 Q3 | 12.81 Million USD | 31.58% |
| 2003 Q2 | 9.74 Million USD | 21.05% |
| 2003 Q1 | 8.04 Million USD | -7.7% |
| 2003 Q4 | 12.62 Million USD | -1.52% |
| 2003 FY | 43.23 Million USD | 46.61% |
| 2002 FY | 29.48 Million USD | 29.94% |
| 2002 Q4 | 8.71 Million USD | 14.71% |
| 2002 Q3 | 7.6 Million USD | 6.92% |
| 2002 Q2 | 7.1 Million USD | 17.33% |
| 2002 Q1 | 6.05 Million USD | -11.71% |
| 2001 Q1 | 4.83 Million USD | -12.53% |
| 2001 FY | 22.69 Million USD | 24.15% |
| 2001 Q4 | 6.86 Million USD | 22.05% |
| 2001 Q3 | 5.62 Million USD | 4.61% |
| 2001 Q2 | 5.37 Million USD | 11.24% |
| 2000 Q2 | 4.44 Million USD | 8.32% |
| 2000 Q1 | 4.1 Million USD | 5.13% |
| 2000 FY | 18.27 Million USD | 35.4% |
| 2000 Q4 | 5.52 Million USD | 32.63% |
| 2000 Q3 | 4.16 Million USD | -6.21% |
| 1999 Q1 | 2.6 Million USD | 0.0% |
| 1999 Q3 | 3.7 Million USD | 12.12% |
| 1999 Q2 | 3.3 Million USD | 26.92% |
| 1999 FY | 13.5 Million USD | 37.76% |
| 1999 Q4 | 3.9 Million USD | 5.41% |
| 1998 FY | 9.8 Million USD | 0.0% |
| 1998 Q4 | 2.6 Million USD | -3.7% |
| 1998 Q2 | 2.6 Million USD | 36.84% |
| 1998 Q1 | 1.9 Million USD | 0.0% |
| 1998 Q3 | 2.7 Million USD | 3.85% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -945.51% |
| BrainsWay Ltd. | 31.78 Million USD | -296.659% |
| Cerus Corporation | 156.36 Million USD | 19.37% |
| Envoy Medical, Inc. | 316 Thousand USD | -39798.101% |
| electroCore, Inc. | 16.03 Million USD | -686.513% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -19477.329% |
| IceCure Medical Ltd | 3.22 Million USD | -3804.552% |
| Inogen, Inc. | 315.66 Million USD | 60.059% |
| OrthoPediatrics Corp. | 148.73 Million USD | 15.231% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -5092.669% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -34442.012% |
| MaxCyte, Inc. | 41.28 Million USD | -205.362% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -6357.455% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -113742.236% |
| Orthofix Medical Inc. | 746.64 Million USD | 83.114% |
| PAVmed Inc | 2.45 Million USD | -5041.843% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -459.874% |
| RxSight, Inc. | 89.07 Million USD | -41.538% |
| Sight Sciences, Inc. | 81.05 Million USD | -55.544% |
| SI-BONE, Inc. | 138.88 Million USD | 9.222% |
| TELA Bio, Inc. | 58.45 Million USD | -115.691% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 32.621% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -813.542% |
| Acutus Medical, Inc. | 7.16 Million USD | -1659.883% |
| Talis Biomedical Corporation | 412 Thousand USD | -30501.456% |
| Spectral AI, Inc. | 18.05 Million USD | -598.261% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -1172.872% |
| CVRx, Inc. | 39.29 Million USD | -220.85% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -12915.094% |
| Bioventus Inc. | 512.34 Million USD | 75.392% |
| Venus Concept Inc. | 76.35 Million USD | -65.123% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -581.098% |
| LivaNova PLC | 1.15 Billion USD | 89.07% |
| 908 Devices Inc. | 50.22 Million USD | -151.006% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 73.857% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -163544.151% |
| NeuroPace, Inc. | 65.42 Million USD | -92.718% |
| LENSAR, Inc. | 42.16 Million USD | -199.018% |
| Apyx Medical Corporation | 52.34 Million USD | -140.841% |
| Cutera, Inc. | 212.36 Million USD | 40.633% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -277.954% |
| BioSig Technologies, Inc. | 18 Thousand USD | -700333.333% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 24.351% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -426.312% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 91.821% |
| Axonics, Inc. | 366.37 Million USD | 65.588% |
| Outset Medical, Inc. | 130.37 Million USD | 3.297% |
| IRIDEX Corporation | 51.86 Million USD | -143.07% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 7.426% |
| IRadimed Corporation | 65.56 Million USD | -92.303% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -10620.918% |
| INVO Bioscience, Inc. | 3.02 Million USD | -4073.973% |
| Telesis Bio, Inc. | 27.5 Million USD | -358.315% |
| Viemed Healthcare, Inc. | 183 Million USD | 31.108% |
| Varex Imaging Corporation | 811 Million USD | 84.454% |
| Quipt Home Medical Corp. | 221.74 Million USD | 43.142% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -83.586% |
| Dynatronics Corporation | 32.53 Million USD | -287.527% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -1352.846% |
| Semler Scientific, Inc. | 68.18 Million USD | -84.908% |
| InMode Ltd. | 492.04 Million USD | 74.377% |
| Bruker Corporation | 2.96 Billion USD | 95.747% |
| Cytosorbents Corporation | 36.34 Million USD | -246.85% |
| DexCom, Inc. | 3.62 Billion USD | 96.519% |
| Align Technology, Inc. | 3.86 Billion USD | 96.736% |
| Viveve Medical, Inc. | 6.42 Million USD | -1861.998% |
| ZimVie Inc. | 457.43 Million USD | 72.438% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 34.68% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -113742.236% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 83.138% |
| Profound Medical Corp. | 7.33 Million USD | -1619.788% |
| Insulet Corporation | 1.69 Billion USD | 92.571% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| iCAD, Inc. | 17.31 Million USD | -628.017% |
| Nuwellis, Inc. | 8.86 Million USD | -1322.36% |
| Biotricity, Inc. | 12.06 Million USD | -945.133% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 74.41% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -1931.878% |
| PAVmed Inc. | 2.45 Million USD | -5041.843% |
| BIOLASE, Inc. | 49.16 Million USD | -156.444% |
| Beyond Air, Inc. | 1.15 Million USD | -10778.171% |
| FONAR Corporation | 102.88 Million USD | -22.544% |
| AxoGen, Inc. | 159.01 Million USD | 20.712% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 54.057% |
| Inari Medical, Inc. | 493.63 Million USD | 74.459% |
| UFP Technologies, Inc. | 400.07 Million USD | 68.486% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -677738.71% |
| Tenon Medical, Inc. | 2.92 Million USD | -4205.943% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -1750.812% |
| AdaptHealth Corp. | 3.2 Billion USD | 96.06% |
| Sintx Technologies, Inc. | 2.62 Million USD | -4699.315% |
| NanoVibronix, Inc. | 2.28 Million USD | -5422.47% |
| Quanterix Corporation | 122.36 Million USD | -3.032% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -416.607% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 37.125% |
| TransMedics Group, Inc. | 241.62 Million USD | 47.82% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -810.048% |
| NeuroMetrix, Inc. | 5.9 Million USD | -2036.399% |
| Hyperfine, Inc. | 11.03 Million USD | -1042.839% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 23.659% |
| Biomerica, Inc. | 5.41 Million USD | -2228.31% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -149.358% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 28.823% |